National Bank of Canada
BCTXW

National Bank of Canada’s BriaCell Therapeutics Corp Warrant BCTXW Stock Holding History

National Bank of Canada’s Portfolio BCTXW Stock Details BCTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-178
Closed -$100K – 2763
2022
Q3 		$100K Buy
+178
New +$532 ﹤0.01% 1522
2022
Q2 		– Sell
-90
Closed -$91K – 2783
2022
Q1 		$91K Sell
90
-2,051
-96% -$8.16K ﹤0.01% 1690
2021
Q4 		$1.77M Buy
+2,141
New +$10.1K 0.01% 861

Other funds holding BCTXW

M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
KJHP
K.J. Harrison & Partners Toronto, Ontario, Canada $706M AUM 48.92% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return